CAS No.: 2381089-83-2 Retatrutide Chemical Structure Molecular formula:C 221 H 342 N 46 O 68 Molecular weight: 4731.33 Patent period: Compound: 2026 Composition: 2029 Dositive specifications: Injection (type II diabetes, OZEMPIC): Oral tablets: Injection : Products are for laboratory research use only
Source: [5] Against this, resting heart rate rises by 5 to 10 beats per minute, consistent with the known class effect of GLP-1 receptor agonists [5]
Combining these profiles introduces unpredictable interaction risks that have not been characterised in any clinical setting
This reflects the GIP component, which appears to moderate GLP-1-driven GI effects
Signs of injection site infection: increasing redness that spreads beyond the injection area, warmth, swelling that worsens over 24 to 48 hours, pus or discharge, fever, or red streaks extending from the injection site
Push the plunger slowly